— Know what they know.
Not Investment Advice
Also trades as: 94E.F (FSX) · $vol 0M

ZURA NASDAQ

Zura Bio Limited
1W: +1.7% 1M: -27.5% 3M: -23.3% YTD: -25.9% 1Y: +1.7% 3Y: -39.1%
$4.11
-0.03 (-0.72%)
 
Weekly Expected Move ±7.5%
$3 $4 $4 $4 $5
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 30 · $390.4M mcap · 51M float · 2.73% daily turnover · Short 65% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE
32.9 / 100
NoneWeakNarrowWide
Primary source: Network Effects  ·  ROIC: 910.3%
Cost Advantage
33
Intangibles
25
Switching Cost
38
Network Effect
43
Scale
27
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. ZURA has No discernible competitive edge (32.9/100). The business operates without significant structural advantages. The primary source of advantage is Network Effects. ROIC of 910.3% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$20
Low
$20
Avg Target
$20
High
Based on 1 analyst since Aug 11, 2026 earnings
Analyst Recommendations
Strong Buy: 1Buy: 6Hold: 1Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$20.00
Analysts1
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-08-12 Guggenheim Yatin Suneja $15 $20 +5 +259.7% $5.56
2026-02-09 Wedbush — Initiated $15 — +149.6% $6.01
2025-04-03 H.C. Wainwright Mitchell Kapoor $5 $3 -2 +175.2% $1.09
2024-11-08 Guggenheim Yatin Suneja Initiated $15 — +227.5% $4.58
2024-09-05 H.C. Wainwright Mitchell Kapoor Initiated $5 — +26.6% $3.95

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C-
Oct 02, 2026
DCF
3
ROE
1
ROA
1
D/E
1
P/E
1
P/B
2
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. ZURA receives an overall rating of C-. Areas of concern: ROE (1/5), ROA (1/5), D/E (1/5), P/E (1/5), P/B (2/5).
Rating Change History
DateFromTo
2026-08-10 C C-
2026-07-27 C- C
2026-01-22 C C-
2026-01-14 C- C
2026-01-08 C C-
2026-01-07 C- C
2025-12-30 C C-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ — Grade A+
Profitability
—
Balance Sheet
85
Earnings Quality
59
Growth
—
Value
36
Momentum
—
Safety
100
Cash Flow
—

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
25.47
Safe Zone
Piotroski F-Score
2/9
✗ ✗ ✗ ✓ ✗ ✓ ✗ ✗ ✗
Beneish M-Score
—
—
Ohlson O-Score
0.08
Bankruptcy prob: 52.0%
High Risk
Credit Rating
AA
Score: 89.0/100
Trend: Improving
Earnings Quality
—
OCF/NI: 0.88x
Accruals: -5.5%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. ZURA scores 25.47, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. ZURA scores 2/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. ZURA's implied 52.0% bankruptcy probability signals significant financial distress. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. ZURA receives an estimated rating of AA (score: 89.0/100), with a improving trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-3.64x
PEG
0.07x
P/S
0.00x
P/B
2.64x
P/FCF
-9.64x
P/OCF
—
EV/EBITDA
-6.33x
EV/Revenue
—
EV/EBIT
-6.33x
EV/FCF
-6.99x
Earnings Yield
-11.73%
FCF Yield
-10.38%
Shareholder Yield
0.00%
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. ZURA currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.022
NI / EBT
×
Interest Burden
1.000
EBT / EBIT
×
EBIT Margin
—
EBIT / Rev
×
Asset Turnover
0.000
Rev / Assets
×
Equity Multiplier
1.149
Assets / Equity
=
ROE
-54.3%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. ZURA's ROE of -54.3% is driven by A tax burden ratio of 1.02 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 888 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$4.11
Median 1Y
$1.56
5th Pctile
$0.21
95th Pctile
$11.41
Ann. Volatility
127.3%
Analyst Target
$20.00
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Robert Lisicki
Chief Executive Officer
$537,751 $— $6,659,601
Kiran Nistala Medical
edical Officer and Head of Development
$409,600 $— $2,530,975
Kim Davis Operating
rating Officer, Chief Legal Officer and Corporate Secretary
$437,395 $— $1,795,651
Someit Sidhu
Former Chief Executive Officer
$148,415 $— $1,011,553

CEO Pay Ratio

8:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $6,659,601
Avg Employee Cost (SGA/emp): $829,100
Employees: 40

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
40
+33.3% YoY
Revenue / Employee
—
Profit / Employee
$-2,483,825
NI: $-99,353,000
SGA / Employee
$829,100
Avg labor cost proxy
R&D / Employee
$1,052,050
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE -34.4% -63.3% -82.1% -1.0% -1.3% -30.9% -43.7% -46.4% -57.7% -44.7% -47.9% -56.9% -43.6% -54.3% -54.33%
ROA -21.6% -38.5% -49.6% -59.9% -86.8% -23.0% -32.2% -34.1% -43.7% -36.4% -37.5% -48.1% -38.6% -47.3% -47.27%
ROIC 37.9% 74.9% 1.0% 1.2% 1.7% 1.0% 1.1% 1.5% 1.6% 2.0% 1.9% 7.6% 7.4% 9.1% 9.10%
ROCE -19.6% -44.6% -59.2% -77.8% -83.5% -23.6% -29.4% -33.2% -42.2% -50.5% -58.2% -71.4% -35.7% -43.5% -43.55%
Gross Margin — — — — — — — — — — — — — — —
Operating Margin — — — — — — — — — — — — — — —
Net Margin — — — — — — — — — — — — — — —
EBITDA Margin — — — — — — — — — — — — — — —
FCF Margin — — — — — — — — — — — — — — —
OCF Margin — — — — — — — — — — — — — — —
ROE 3Y Avg snapshot only -38.98%
ROA 3Y Avg snapshot only -33.18%
ROIC Economic snapshot only -37.18%
Cash ROA snapshot only -36.34%
Valuation
Metric Trend Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio -55.25 -6.45 -5.96 -3.64 -2.06 -7.53 -7.50 -3.41 -1.46 -1.57 -6.55 -6.98 -8.62 -8.53 -3.637
P/S Ratio — — — — — — — — — — — — — — 0.000
P/B Ratio 19.03 4.08 4.89 3.70 1.98 1.68 2.32 1.11 0.61 0.79 3.78 4.86 3.08 3.80 2.644
P/FCF -162.71 -19.84 -16.28 -9.53 -4.05 -10.29 -13.46 -4.92 -2.46 -2.27 -7.65 -7.60 -9.18 -9.64 -9.637
P/OCF — — — — — — — — — — — — — — —
EV/EBITDA -62.96 -4.06 -3.98 -1.92 -0.49 -1.80 -3.31 0.25 1.35 0.79 -3.92 -5.30 -5.71 -6.33 -6.332
EV/Revenue — — — — — — — — — — — — — — —
EV/EBIT -62.96 -4.05 -3.97 -1.91 -0.49 -1.80 -3.31 0.25 1.35 0.79 -3.92 -5.29 -5.70 -6.33 -6.327
EV/FCF -149.21 -11.88 -10.82 -5.20 -1.03 -2.90 -6.32 0.40 2.52 1.27 -5.05 -5.91 -6.08 -6.99 -6.995
Earnings Yield -1.8% -15.5% -16.8% -27.5% -48.5% -13.3% -13.3% -29.3% -68.3% -63.8% -15.3% -14.3% -11.6% -11.7% -11.73%
FCF Yield -0.6% -5.0% -6.1% -10.5% -24.7% -9.7% -7.4% -20.3% -40.7% -44.1% -13.1% -13.2% -10.9% -10.4% -10.38%
PEG Ratio snapshot only 0.074
Price/Tangible Book snapshot only 3.796
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 8.89 5.68 6.15 4.97 6.17 12.57 10.36 9.16 8.14 8.40 5.58 9.05 19.33 12.90 12.900
Quick Ratio 8.89 5.68 6.15 4.97 6.17 12.57 10.36 9.16 8.14 8.40 5.58 9.05 19.33 12.90 12.900
Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Net Debt/Equity -1.58 -1.64 -1.64 -1.68 -1.47 -1.20 -1.23 -1.20 -1.23 -1.23 -1.28 -1.08 -1.04 -1.04 -1.041
Debt/Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Debt/EBITDA -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.000
Net Debt/EBITDA 5.70 2.72 2.01 1.60 1.42 4.58 3.74 3.33 2.67 2.20 2.02 1.51 2.91 2.39 2.392
Interest Coverage — — — — — — — — — — — — — — —
Equity Multiplier 1.59 1.64 1.65 1.70 1.48 1.21 1.24 1.22 1.25 1.25 1.33 1.12 1.05 1.08 1.083
Cash Ratio snapshot only 12.571
Defensive Interval snapshot only 807.3 days
Efficiency & Turnover
Metric Trend Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Inventory Turnover — — — — — — — — — — — — — — —
Receivables Turnover — — — — — — — — — — — — — — —
Payables Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.04 0.01 0.02 0.023
DSO — — — — — — — — — — — — — — —
DIO — — — — — — — 0 0 0 0 0 0 0 0.0 days
DPO — — — — — — — 127093 99791 80117 41197 9555 43435 15708 15708.0 days
Cash Conversion Cycle — — — — — — — — — — — — — — —
Fixed Asset Turnover snapshot only 0.000
Cash Velocity snapshot only 0.000
Growth (YoY)
Metric Trend Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue — — — — — — — — — — — — — — —
Net Income — — — — -5.1% 20.2% 8.9% 20.8% 1.7% -81.5% -32.3% -47.7% -34.6% -38.9% -38.86%
EPS — — — — -3.6% 63.5% 51.1% 42.9% 29.4% -44.2% -22.2% -2.4% 21.7% -3.3% -3.26%
FCF — — — — -8.1% -79.8% -38.6% -43.8% -15.1% -71.4% -1.0% -95.9% -1.1% -77.7% -77.68%
EBITDA — — — — -7.2% 0.8% 2.7% 15.1% -1.2% -70.7% -37.1% -36.6% -21.1% -22.1% -22.11%
Op. Income — — — — -7.2% 1.1% 2.9% 11.9% -4.4% -75.9% -44.3% -36.3% -23.4% -28.2% -28.17%
OCF Growth snapshot only -77.98%
Asset Growth snapshot only 35.23%
Equity Growth snapshot only 56.53%
Shares Change snapshot only 34.48%
Growth (CAGR)
Metric Trend Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y — — — — — — — — — — — — — — —
Revenue 5Y — — — — — — — — — — — — — — —
EPS 3Y — — — — — — — — — — — — — — —
EPS 5Y — — — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — — — —
Net Income 5Y — — — — — — — — — — — — — — —
EBITDA 3Y — — — — — — — — — — — — — — —
EBITDA 5Y — — — — — — — — — — — — — — —
Gross Profit 3Y — — — — — — — — — — — — — — —
Gross Profit 5Y — — — — — — — — — — — — — — —
Op. Income 3Y — — — — — — — — — — — — — — —
Op. Income 5Y — — — — — — — — — — — — — — —
FCF 3Y — — — — — — — — — — — — — — —
FCF 5Y — — — — — — — — — — — — — — —
OCF 3Y — — — — — — — — — — — — — — —
OCF 5Y — — — — — — — — — — — — — — —
Assets 3Y — — — — — — — — — — — — 72.7% 23.5% 23.49%
Assets 5Y — — — — — — — — — — — — — — —
Equity 3Y — — — — — — — — — — — — 98.2% 41.9% 41.95%
Book Value 3Y — — — — — — — — — — — — 35.1% -8.2% -8.20%
Dividend 3Y — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability — — — — — — — — 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earnings Stability — — — — — — — — 0.73 0.45 0.46 0.20 0.82 0.78 0.781
Margin Stability — — — — — — — — — — — — — — —
Rev. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.00 0.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence — — — — — — — — 0.99 0.50 0.87 0.81 0.86 0.84 0.845
Earnings Smoothness — — — — — — — — — — — — — — —
ROE Trend — — — — — — — — 0.24 -0.07 -0.01 -0.02 0.33 -0.08 -0.083
Gross Margin Trend — — — — — — — — — — — — — — —
FCF Margin Trend — — — — — — — — — — — — — — —
Sustainable Growth Rate — — — — — — — — — — — — — — —
Internal Growth Rate — — — — — — — — — — — — — — —
Cash Flow Quality
Metric Trend Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 0.34 0.19 0.21 0.25 0.29 0.52 0.45 0.59 0.59 0.69 0.85 0.92 0.94 0.88 0.884
FCF/OCF 1.00 1.68 1.73 1.53 1.78 1.40 1.24 1.18 1.00 1.00 1.00 1.00 1.00 1.00 1.001
FCF/Net Income snapshot only 0.885
CapEx/Revenue — — — — — — — — — — — — — — —
CapEx/Depreciation snapshot only 1.410
Accruals Ratio -0.14 -0.31 -0.39 -0.45 -0.62 -0.11 -0.18 -0.14 -0.18 -0.11 -0.06 -0.04 -0.02 -0.05 -0.055
Sloan Accruals snapshot only 0.301
Cash Flow Adequacy snapshot only -901.708
Dividends & Buybacks
Metric Trend Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — — — — — — — — — — — — —
FCF Payout Ratio — — — — — — — — — — — — — — —
Total Payout Ratio — — — — — — — — — — — — — — —
Div. Increase Streak — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — —
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -10.7% -42.8% -37.6% -53.0% -49.5% -19.5% -17.1% 0.0% -6.0% -50.6% -13.6% -1.1% -20.3% -18.1% -18.14%
Total Shareholder Return -10.7% -42.8% -37.6% -53.0% -49.5% -19.5% -17.1% 0.0% -6.0% -50.6% -13.6% -1.1% -20.3% -18.1% -18.14%
DuPont Factors
Metric Trend Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 0.98 1.00 1.00 1.00 1.00 1.00 1.00 0.91 0.93 0.93 0.96 1.03 1.03 1.02 1.022
Interest Burden (EBT/EBIT) 1.27 1.05 1.01 0.97 0.92 0.85 0.94 0.99 0.97 0.96 0.94 0.95 0.97 1.00 1.000
EBIT Margin — — — — — — — — — — — — — — —
Asset Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Equity Multiplier 1.59 1.64 1.65 1.70 1.52 1.34 1.36 1.36 1.32 1.23 1.27 1.18 1.13 1.15 1.149
Per Share
Metric Trend Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $-0.27 $-1.27 $-1.11 $-1.28 $-1.25 $-0.46 $-0.54 $-0.73 $-0.88 $-0.67 $-0.66 $-0.75 $-0.69 $-0.69 $-0.69
Book Value/Share $0.78 $2.01 $1.35 $1.26 $1.30 $2.09 $1.75 $2.25 $2.12 $1.34 $1.14 $1.08 $1.93 $1.55 $1.55
Tangible Book/Share $0.78 $2.01 $1.35 $1.26 $1.30 $2.09 $1.75 $2.25 $2.12 $1.34 $1.14 $1.08 $1.93 $1.55 $1.55
Revenue/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
FCF/Share $-0.09 $-0.41 $-0.41 $-0.49 $-0.63 $-0.34 $-0.30 $-0.51 $-0.52 $-0.46 $-0.57 $-0.69 $-0.65 $-0.61 $-0.61
OCF/Share $-0.09 $-0.25 $-0.23 $-0.32 $-0.36 $-0.24 $-0.24 $-0.43 $-0.52 $-0.46 $-0.56 $-0.69 $-0.65 $-0.61 $-0.61
Cash/Share $1.24 $3.29 $2.22 $2.12 $1.91 $2.51 $2.16 $2.70 $2.61 $1.64 $1.47 $1.16 $2.01 $1.62 $1.62
EBITDA/Share $-0.22 $-1.21 $-1.10 $-1.33 $-1.35 $-0.55 $-0.58 $-0.81 $-0.98 $-0.74 $-0.73 $-0.77 $-0.69 $-0.68 $-0.68
Debt/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Net Debt/Share $-1.24 $-3.29 $-2.22 $-2.12 $-1.91 $-2.51 $-2.16 $-2.70 $-2.61 $-1.64 $-1.47 $-1.16 $-2.01 $-1.62 $-1.62
Academic Models
Metric Trend Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — 25.469
Altman Z-Prime snapshot only 47.205
Piotroski F-Score 2 2 2 2 1 3 3 3 3 1 1 1 2 2 2
Beneish M-Score — — — — — — — — — — — — — — —
Ohlson O-Score snapshot only 0.081
ROIC (Greenblatt) snapshot only -44.16%
Net-Net WC snapshot only $1.53
Credit
Metric Trend Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only AA
Credit Score 89.00 89.00 89.00 89.00 74.50 89.00 89.00 89.00 70.03 70.06 89.00 89.00 89.00 89.00 89.000
Credit Grade snapshot only 3
Credit Trend snapshot only 18.940
Implied Spread (bps) snapshot only 80.000
Industry Credit Rank snapshot only 91
Sector Credit Rank snapshot only 88

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms